基本信息
浏览量:267
职业迁徙
个人简介
Professor Robin Jones is a medical oncologist with a specialist interest in bone and soft issue sarcomas. He has been principle investigator on numerous phase I, II and III trials.
He completed his medical training at Guy’s and St Thomas’ Hospital, and his oncology training at The Royal Marsden. His postgraduate research degree, with Professor Dowsett at the ICR, evaluated potential predictive and prognostic factors in breast cancer patients treated with neoadjuvant chemotherapy.
In January 2010 he was appointed Associate Professor and Director of the Sarcoma Program at the University of Washington and Fred Hutchinson Cancer Research Center in Seattle. He led a successful clinical and research program and continued his translational and trial-based research. The laboratory work with Dr Seth Pollack evaluated novel immunotherapeutic targets in bone and soft tissue sarcomas, and has led to a number of early-phase immunotherapeutic clinical trials.
He is Consultant Medical Oncologist and Reader at the Royal Marsden and ICR. He is currently working on a number of trials of investigational agents in sarcomas as well as laboratory-based studies with Dr Paul Huang.
He is a member of the Sarcoma Alliance for Research through Collaboration (SARC) concept review committee, European Organization for Research and Treatment of Cancer (EORTC) Sarcoma Group, the American Joint Committee on Cancer (AJCC) soft tissue sarcoma staging panel. He has previously served on the American Society of Clinical Oncology (ASCO) Educational Committee and the National Comprehensive Cancer Network (NCCN) Bone Tumour Panel.
He completed his medical training at Guy’s and St Thomas’ Hospital, and his oncology training at The Royal Marsden. His postgraduate research degree, with Professor Dowsett at the ICR, evaluated potential predictive and prognostic factors in breast cancer patients treated with neoadjuvant chemotherapy.
In January 2010 he was appointed Associate Professor and Director of the Sarcoma Program at the University of Washington and Fred Hutchinson Cancer Research Center in Seattle. He led a successful clinical and research program and continued his translational and trial-based research. The laboratory work with Dr Seth Pollack evaluated novel immunotherapeutic targets in bone and soft tissue sarcomas, and has led to a number of early-phase immunotherapeutic clinical trials.
He is Consultant Medical Oncologist and Reader at the Royal Marsden and ICR. He is currently working on a number of trials of investigational agents in sarcomas as well as laboratory-based studies with Dr Paul Huang.
He is a member of the Sarcoma Alliance for Research through Collaboration (SARC) concept review committee, European Organization for Research and Treatment of Cancer (EORTC) Sarcoma Group, the American Joint Committee on Cancer (AJCC) soft tissue sarcoma staging panel. He has previously served on the American Society of Clinical Oncology (ASCO) Educational Committee and the National Comprehensive Cancer Network (NCCN) Bone Tumour Panel.
研究兴趣
论文共 706 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
FRONTIERS IN ONCOLOGY (2024)
Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Brian Andrew Van Tine, Christopher T. Chen,Victor Moreno,Elizabeth J. Davis,Maria J. de Miguel,Antoine Italiano,Esma Saada-Bouzid,Mohammed Milhem,Claudia Valverde,Sant P. Chawla,Abdul Rafeh Naqash, Louise Carter,
Cancer Researchno. 7_Supplement (2024)
Annals of oncology : official journal of the European Society for Medical Oncology (2024)
Rare Tumors (2024): 20363613241234207-20363613241234207
Su Yin Lim, Laura Ferro-Lopez, Elizabeth Barquin, Daniel Lindsay,Khin Thway,Myles J. Smith,Charlotte Benson,Robin L. Jones,Andrea Napolitano
CANCERSno. 5 (2024): 985
CLINICAL CANCER RESEARCHno. 4 (2024): 719-728
C. Serrano, S. Rothschild, G. Villacampa, M. C. Heinrich, S. George, J. -Y. Blay, J. K. Sicklick, G. K. Schwartz, S. Rastogi,R. L. Jones, P. Rutkowski, N. Somaiah,
ESMO OPENno. 1 (2024): 102218-102218
Frontiers in Oncology (2024): 1367237-1367237
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn